MoneyWorks4Me

Gujarat Themis Biosyn informs about financial highlights

15 May 2023 Evaluate

Pursuant to Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Themis Biosyn has informed that it enclosed Financial Highlights issued by the Company on its financial results for the Quarter and year ended 31st March, 2023.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..